Previous close | 25.59 |
Open | 25.88 |
Bid | 25.64 x 600 |
Ask | 25.67 x 1200 |
Day's range | 25.36 - 26.11 |
52-week range | 18.09 - 32.00 |
Volume | |
Avg. volume | 1,772,665 |
Market cap | 3.812B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed the benchmark in the quarter. The small-cap growth universe revealed a stark dichotomy despite the positive performance of the benchmark Russell 2000 Growth Index, which […]
Insmed ( NASDAQ:INSM ) Full Year 2023 Results Key Financial Results Revenue: US$305.2m (up 24% from FY 2022). Net loss...